Table 1. Characteristics of the study population.
| HBsAg negative | HBsAg positive | Total | |||
| n = 247 (90.8%) | n = 25 (9.2%) | (n = 272) | p-value | ||
| Gender (male) | 88 (35.6%) | 15 (60%) | 103 (37%) | 0.017 | |
| Age (y) | 38 (32–48) | 42 (38–56) | 38 (32–47) | 0.18 | |
| WHO Stage | I | 153 (61.9%) | 12 (48%) | 165 (60.6%) | |
| II | 51 (20.6%) | 6 (24%) | 57 (20.9%) | ||
| III | 32 (12.9%) | 6 (24%) | 38 (13.9%) | ||
| IV | 11 (4.4%) | 1 (4%) | 12 (4.4%) | 0.417 | |
| CD4+ Count (/µL) | 260 (99–441) | 130 (76–349) | 250 (97–439) | 0.25 | |
| ALT (U/l) | 32 (23–45) | 42 (30–75) | 32 (23–46) | 0.006 | |
| Creatinine (µmol/L) | 73 (58–86) | 73 (50–93) | 73 (58–86) | 0.81 | |
| Anti-HCV (positive) | 9 (3.6%) | 1 (4%) | 10 (3.7%) | 0.92 | |
| HBeAg (positive) | not tested | 7 (28%) | not tested | – | |
| Anti-HBeAg (positive) | not tested | 18 (72%) | not tested | – | |
Abbreviations: ALT, alanine aminotransferase; ARV, antiretroviral; HBe-Ag, Hepatitis B envelope antigen; HBsAg, Hepatitis B surface antigen; HCV, Hepatitis C virus; y, years.
Data are presented as median (interquartile range) for continuous variables and as count (column percentage) for categorical variables. P values hypothesis testing between HBsAg positive and HBsAg negative are derived from Mann-Whitney U test for continuous and χ2-test for categorical variables.